HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 48 | 54 | 88.9% | |
| HF004 | 2020 | 125 | 142 | 88.0% | |
| HF006 | 2021 | 159 | 172 | 92.4% | |
| HF006 | 2022 | 237 | 256 | 92.6% | |
| HF006 | 2023 | 244 | 257 | 94.9% |
